Establishment and characterization of 12 uterine cervical-carcinoma cell lines: Common sequence variation in the E7 gene of HPV-16-positive cell lines

International Journal of Cancer

Volumn 72, Issue 2, 1997, Pages 313-320

  Ku, Ja Lok ^a   Kim, Woo Ho ^b   Park, Hyun Sook ^a   Kang, Soon Beom ^b   Park, Jae Gahb ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; DNA FINGERPRINTING; DNA REPLICATION; DNA SEQUENCE; EPISOME; GENE SEQUENCE; GENETIC HETEROGENEITY; HELA CELL; HUMAN; HUMAN CELL; KERATINIZATION; PRIORITY JOURNAL; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; VIRUS GENE; WART VIRUS;

CARCINOMA; FEMALE; GENES, VIRAL; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; SEQUENCE ANALYSIS; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0030848366     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970717)72:2<313::AID-IJC19>3.0.CO;2-G     Document Type: Article

References (30)

1. BRAUN, L., MIKUMO, R., MARK, H.F. and LAUCHLAN, S., Analysis of the growth properties and physical state of the human-papillomavirus-type-16 genome in cell lines derived from primary cervical tumors. Amer. J. Pathol., 143, 832-844 (1993).
2. BROWER, M., CARNEY, D.N., OIE, H.K., GAZDAR, A.F. and MINNA, J.D., Growth of cell lines and clinical specimens of human non-small-cell lung cancer in a serum-free defined medium. Cancer Res., 46, 798-806 (1986).
3. CHEN, C.M., SHYU, M.P., AU, L.C., CHU, H.W., CHENG, W.T.K. and CHOO, K.B., Analysis of deletion of the integrated human-papillomavirus-16 sequence in cervical cancer: a rapid multiplex polymerase-chain-reaction approach. J. med. Virol., 44, 206-211 (1994).
4. COLE, S.T. and DANOS, O., Nucleotide sequence and comparative analysis of the human-papillomavirus-type-18 genome: phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products. J. mol. Biol., 193, 599-698 (1987).
5. COLE, S.T. and STREECK, R.E., Genome organization and nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer. J. Virol., 58, 991-995 (1986).
6. ESCHLE, D., DÜRST, M., TER MEULEN, J., LUANDE, J., EBERHARDT, H.C., PAWLITA, M. and GISSMANN, L., Geographical dependence of sequence variation in the E7 gene of human papillomavirus type 16. J. gen. Virol., 73, 1829-1823 (1992).
7. FUJITA, M., INOUE, M., TANIZAWA, O., IWAMOTO, S. and ENOMOTO, T., Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Cancer Res., 52, 5323-5328 (1992).
8. GOLDSBOROUGH, M.D., DISELVESTRE, D., TEMPLE, G.F. and LORINCZ, A.T., Nucleotide sequence of human papillomavirus type 31: a cervical-neoplasia-associated virus. Virology, 171, 306-311 (1989).
9. HONMA, M., KATAOKA, E., OHNISHI, K., OHNO, T., TAKEUCHI, M., NOMURA, N. and MIZUSAWA, H., A new DNA-profiling system for cell-line identification for use in cell banks in Japan. In Vitro Cell Dev. Biol., 28, 24-28 (1991).
10. JEON, S. and LAMBERT, P.F., Integration of human-papillomavirus-type-16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc. nat. Acad. Sci. (Wash.), 92, 1654-1658 (1995).
11. KANG, M.S., LEE, H.J., LEE, J.H., KU, J.L., LEE, K.P., KELLY, M.J., WON, Y.J., KIM, S.T. and PARK, J.G., Mutation of p53 gene in hepatocellular-carcinoma cell lines with HBX DNA. Int. J. Cancer, 67, 898-902 (1996).
12. MCINTYRE, M.C., FRATTINI, M.G., GROSSMAN, S.R. and LAIMINS, L.A., Human-papillomavirus-type-18 E7 protein requires intact Cys-X-X-Cys motifs for zinc binding, dimerization, and transformation but not tor Rb binding. J. Virol., 67, 3142-3150 (1993).
13. MÜNGER, K., WERNESS, B.A., DYSON, N., PHELPS, W.C., HARLOW, E. and HOWLEY, P.M., Complex formation of human-papillomavirus E7 proteins with the retinoblastoma tumor-suppressor gene product. EMBO J., 8, 4099-4105 (1989).
14. PAHEL, G., AULABAUGH, A., SHORT, S.A., BARNES, J.A., PAINTER, G.R., RAY, P. and PHELPS, W.C., Structural and functional characterization of the HPV-16 E7 protein expressed in bacteria. J. biol. Chem., 268, 26018-26025 (1993).
15. PAO, C.C., LIN, C.U., CHANG, Y.L., TSENG, C.J. and HSUEH, S., Human papillomaviruses and small-cell carcinoma of the uterine cervix. Gynecol. Oncol., 43, 206-210 (1991).
16. PARK, J.-G. and 17 others, Characterization of cell lines established from human hepatocellular carcinoma. Int. J. Cancer, 62, 276-282 (1993).
17. PARK, J.-G., OIE, H.K., SUGARBAKER, P.H., HENSLEE, J.G., CHEN, T.-R., JOHNSON, B.E. and GAZDAR, A., Characteristics of cell lines established from human colorectal carcinoma. Cancer Res., 47, 6710-6718 (1987).
18. PAZDUR, R., BONOMI, P. and SLAYTON, R., Neuro-endocrine carcinoma of the cervix: implications for staging and therapy. Gynecol. Oncol., 12, 120-128 (1981).
19. RAWADI, G. and DUSSURGET, O., Advances in PCR-based detection of Mycoplasmas contaminating cell cultures. PCR Methods Applications, 4, 199-208 (1995).
20. SCHEFFNER, M., WERNESS, B.A., HUIBREGSTE, J.M., LEVINE, A.J. and HOWLEY, P.M., The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation ot p53. Cell, 63, 1129-1136 (1990).
21. SCHWARZ, E., FREESE, U.K., GISSMANN, L., MAYER, W., ROGGENBUCK, B., STREMLAU, A. and ZUR HAUSEN, H., Structure and transcription of human-papillomavirus sequences in cervical-carcinoma cells. Nature (Lond.), 314, 111-114 (1985).
22. SEEDORF, K., KAREMMER, G., DUERST, M., SUHAI, S. and ROEWEKAMP, W.G., Human-papillomavirus-type-16 DNA sequence. Virology, 145, 181-185 (1985).
23. SHAH, K.V. and HOWLEY, P.M., Papillomaviruses. In: B.N. Fields and D.M. Knife (eds.), Virology (2nd ed.), pp. 1651-1676. Raven Press, New York (1990).
24. SHIMADA, M., FUKUSHIMA, M., MUKAI, H., KATO, I., NISHIKAWA, A. and FUJINAGA, K., Amplification and specific detection of transforming gene region of human papillomavirus 16, 18 and 33 in cervical carcinoma by means of the polymerase chain reaction. Jap. J. Cancer. Res., 81, 1-5 (1990).
25. SPENCE, R.P., MURRAY, A., BANKS, L., KELLAND, L.R. and CRAWFORD, L., Analysis of human papilloma sequences in cell lines recently derived from cervical cancers. Cancer Res., 48, 324-328 (1988).
26. STOLER, M.H., MILLS, S.E., GERSELL, D.J. and WALKER, A.N., Small-cell neuro-endocrine carcinoma of the cervix. Amer. J. surg. Pathol., 15, 28-32 (1991).
27. TER MEULEN, J., SCHWEIGLER, A.C., EBERHARDT, H.C., LUANDE, J., MGAYA, H.N., MÜLLER, M., BLEUL, C., ULKEN, V., IKENBERG, H., PAWLITA, M. and GISSMAN, L., Sequence variation in the E7 gene of human papillomavirus type 18 in tumor and non-tumor patients and antibody response to a conserved seroreactive epitope. Int. J. Cancer. 53, 237-259 (1993).
28. VOGELSTEIN, B. and KINZLER, K.W., p53 function and dysfunction. Cell, 70, 513-526 (1992).
29. WERNESS, B., LEVINE, A.J. and HOWLEY, P.M., Association of human-papillomavirus-types-16 and -18 E6 proteins with p53. Science, 248, 76-79 (1990).
30. ZUR HAUSEN, H., Human papillomaviruses in the pathogenesis of anogenital cancer. Virology, 184, 9-13 (1991).